Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Kiyonaga Fujii"'
Autor:
Toshihide Nishimura, Ákos Végvári, Haruhiko Nakamura, Kiyonaga Fujii, Hiroki Sakai, Saeko Naruki, Naoki Furuya, Hisashi Saji
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundSolid-predominant lung adenocarcinoma (SPA), which is one of the high-risk subtypes with poor prognosis and unsatisfactory response to chemotherapy and targeted therapy in lung adenocarcinoma, remains molecular profile unclarified. Weighted
Externí odkaz:
https://doaj.org/article/7b32dba8f06749a9ac8d17f402f52292
Autor:
Toshihide Nishimura, Kiyonaga Fujii, Haruhiko Nakamura, Saeko Naruki, Hiroki Sakai, Hiroyuki Kimura, Tomoyuki Miyazawa, Masayuki Takagi, Naoki Furuya, Gyorgy Marko-Varga, Harubumi Kato, Hisashi Saji
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract No therapeutic targets have been identified for lung squamous cell cancer (SqCC) which is the second most prevalent lung cancer because its molecular profiles remain unclear. This study aimed to unveil disease-related protein networks by pro
Externí odkaz:
https://doaj.org/article/8190da51775f4e4ebc64c7a68149a4e8
Autor:
Haruhiko Nakamura, Kiyonaga Fujii, Vipul Gupta, Hiroko Hata, Hirotaka Koizumu, Masahiro Hoshikawa, Saeko Naruki, Yuka Miyata, Ikuya Takahashi, Tomoyuki Miyazawa, Hiroki Sakai, Kouhei Tsumoto, Masayuki Takagi, Hisashi Saji, Toshihide Nishimura
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217105 (2019)
Small-cell lung carcinoma (SCLC) and large-cell neuroendocrine lung carcinoma (LCNEC) are high-grade lung neuroendocrine tumors (NET). However, comparative protein expression within SCLC and LCNEC remains unclear. Here, protein expression profiles we
Externí odkaz:
https://doaj.org/article/0b37966936a54a2d8e049f98b8658b80
Autor:
Tetsuya Fukuda, Masaharu Nomura, Yasufumi Kato, Hiromasa Tojo, Kiyonaga Fujii, Toshitaka Nagao, Yasuhiko Bando, Thomas E Fehniger, György Marko-Varga, Haruhiko Nakamura, Harubumi Kato, Toshihide Nishimura
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0176219 (2017)
Selected reaction monitoring mass spectrometry (SRM-MS) -based semi-quantitation was performed to assess the validity of 46 selected candidate proteins for specifically diagnosing large-cell neuroendocrine lung carcinoma (LCNEC) and differentiating i
Externí odkaz:
https://doaj.org/article/a0d5e290cfce434488dcaea1641bfd69
Autor:
Kuninori Suzuki, Shingo Nakamura, Mayumi Morimoto, Kiyonaga Fujii, Nobuo N Noda, Fuyuhiko Inagaki, Yoshinori Ohsumi
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91651 (2014)
Macroautophagy (autophagy) is a bulk protein-degradation system ubiquitously conserved in eukaryotic cells. During autophagy, cytoplasmic components are enclosed in a membrane compartment, called an autophagosome. The autophagosome fuses with the vac
Externí odkaz:
https://doaj.org/article/d7a27ea399e546529d46095638336795
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 2 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3473b32464825b5041bc3c4dfac2d2a7
https://doi.org/10.1158/1078-0432.22441915
https://doi.org/10.1158/1078-0432.22441915
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 4 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e22ecdcf945daf991dce1518225fc4
https://doi.org/10.1158/1078-0432.22441909
https://doi.org/10.1158/1078-0432.22441909
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Text from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b0d1ad843a027707d18818481d15e9
https://doi.org/10.1158/1078-0432.22441885
https://doi.org/10.1158/1078-0432.22441885
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 3 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3959385d2ca1884dcbd6ae659907290e
https://doi.org/10.1158/1078-0432.22441912.v1
https://doi.org/10.1158/1078-0432.22441912.v1
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 1 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1869d508d425cb74584286b2b83e743e
https://doi.org/10.1158/1078-0432.22441918
https://doi.org/10.1158/1078-0432.22441918